Funded Tech Companies

Glympse Bio

Wondering who backed Glympse Bio? Temasek Holdings, New Leaf Venture Partners and Catalio Capital Management joined the equity holders in this biopharmaceutical company.

Company Overview

Contact Information

Company Background Information

Overview

Glympse Bio is pioneering an in vivo sensing technology dedicated to transforming disease monitoring. The company has built a product engine enabling rapid development of tunable and bioengineered activity sensors for multiple indications including fibrosis, cancer, immunology and infectious diseases.

Profile

Social Media

Company News

Facebook

YouTube

Last Transaction

7/17/2020

Financing History

Management Team

Title

Name

Email & Social

Chief Executive Officer

Caroline Loew

        

Chief Scientific Officer

Wendy Winckler

        

Co-Founder

Sangeeta Bhatia

        

Co-Founder

Gabe Kwong

        

VP - Bus. Development

Tracey Dawson

        

VP - Finance

Martha Denyer

        

VP - Operations

Dhaval Gosalia

        

Company Investors

• Temasek Holdings (Cayce Denton)
• New Leaf Venture Partners
• Catalio Capital Management
• Polaris Partners (Amy Schulman)
• CRV
• Section 32 (Steven Kafka)
• Waterman Ventures
• Arch Venture Partners
• Gilead Sciences
• Greatpoint Ventures Innovation Fund
• DNS Capital
• Heritage Provider Network
• Rivas Capital
• Inevitable Ventures
• Yonghua Capital

Browse more funded tech companies:

Glympse | Glyphic AI

Share this article

About Our VC Funding Database

This tech company profile is powered by VentureDeal.com, a leading provider of venture capital transaction data.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary